Hennessy S, Atsuta Y, Hill S, Rago L, Juhaeri J
Pharmacoepidemiol Drug Saf. 2025; 34(3):e70117.
PMID: 40070104
PMC: 11897686.
DOI: 10.1002/pds.70117.
Ferreira-da-Silva R, Alves J, Vieira C, Silva A, Marques J, Morato M
J Community Health. 2022; 48(2):295-308.
PMID: 36401737
PMC: 9676890.
DOI: 10.1007/s10900-022-01168-3.
ODonnell C, Demler T, Dzierba C
Ment Health Clin. 2022; 12(4):247-253.
PMID: 36071738
PMC: 9405632.
DOI: 10.9740/mhc.2022.08.247.
Zhao Y, Yu Y, Wang H, Li Y, Deng Y, Jiang G
Drug Saf. 2022; 45(5):459-476.
PMID: 35579811
PMC: 9114053.
DOI: 10.1007/s40264-022-01155-6.
Bate A, Hornbuckle K, Juhaeri J, Motsko S, Reynolds R
Ther Adv Drug Saf. 2019; 10:2042098619864744.
PMID: 31428307
PMC: 6683315.
DOI: 10.1177/2042098619864744.
Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.
Oreagba I, Oshikoya K, Ogar C, Adefurin A, Ibrahim A, Awodele O
Pharmacol Res Perspect. 2017; 5(2):e00297.
PMID: 28357123
PMC: 5368961.
DOI: 10.1002/prp2.297.
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
Auffret M, Labreuche J, Duhamel A, Deheul S, Cottencin O, Bordet R
Drug Saf. 2016; 40(3):257-262.
PMID: 27988884
DOI: 10.1007/s40264-016-0489-7.
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Smith M, Sabido-Espin M, Trochanov A, Samuelson M, Guedes S, Corvino F
J Manag Care Spec Pharm. 2015; 21(8):650-60.
PMID: 26233537
PMC: 10398224.
DOI: 10.18553/jmcp.2015.21.8.650.
Initiatives to identify and mitigate medication errors in England.
Cousins D, Gerrett D, Richards N, Jadeja M
Drug Saf. 2015; 38(4):349-57.
PMID: 25735854
DOI: 10.1007/s40264-015-0270-3.
A study on drug safety monitoring program in India.
Ahmad A, Patel I, Sanyal S, Balkrishnan R, Mohanta G
Indian J Pharm Sci. 2014; 76(5):379-86.
PMID: 25425751
PMC: 4243254.
Identifying plausible adverse drug reactions using knowledge extracted from the literature.
Shang N, Xu H, Rindflesch T, Cohen T
J Biomed Inform. 2014; 52:293-310.
PMID: 25046831
PMC: 4261011.
DOI: 10.1016/j.jbi.2014.07.011.
Computing limits on medicine risks based on collections of individual case reports.
Caster O, Noren G, Ralph Edwards I
Theor Biol Med Model. 2014; 11:15.
PMID: 24661640
PMC: 4233652.
DOI: 10.1186/1742-4682-11-15.
Linked health data for pharmacovigilance in children: perceived legal and ethical issues for stakeholders and data guardians.
Hopf Y, Bond C, Francis J, Haughney J, Helms P
BMJ Open. 2014; 4(2):e003875.
PMID: 24523422
PMC: 3927931.
DOI: 10.1136/bmjopen-2013-003875.
Pharmacovigilance in Italy: An overview.
Mazzitello C, Esposito S, Francesco A, Capuano A, Russo E, De Sarro G
J Pharmacol Pharmacother. 2013; 4(Suppl 1):S20-8.
PMID: 24347976
PMC: 3853663.
DOI: 10.4103/0976-500X.120942.
An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study.
Ahmad A, Patel I, Balkrishnan R, Mohanta G, Manna P
Perspect Clin Res. 2013; 4(4):204-10.
PMID: 24312887
PMC: 3835963.
DOI: 10.4103/2229-3485.120168.
Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.
Noren G, Bergvall T, Ryan P, Juhlin K, Schuemie M, Madigan D
Drug Saf. 2013; 36 Suppl 1:S107-21.
PMID: 24166228
DOI: 10.1007/s40264-013-0095-x.
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
Pariente A, Avillach P, Salvo F, Thiessard F, Miremont-Salame G, Fourrier-Reglat A
Drug Saf. 2012; 35(10):855-64.
PMID: 22967190
DOI: 10.1007/BF03261981.
INDI: a computational framework for inferring drug interactions and their associated recommendations.
Gottlieb A, Stein G, Oron Y, Ruppin E, Sharan R
Mol Syst Biol. 2012; 8:592.
PMID: 22806140
PMC: 3421442.
DOI: 10.1038/msb.2012.26.
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports.
Tatonetti N, Fernald G, Altman R
J Am Med Inform Assoc. 2011; 19(1):79-85.
PMID: 21676938
PMC: 3240755.
DOI: 10.1136/amiajnl-2011-000214.
Pharmacovigilance of herbal medicines: Current state and future directions.
Shetti S, Kumar C, Sriwastava N, Sharma I
Pharmacogn Mag. 2011; 7(25):69-73.
PMID: 21472083
PMC: 3065161.
DOI: 10.4103/0973-1296.75905.
